familymednews.com
If you’ve ever noticed yourself thinking about the timing of a plan in two opposing ways—something that feels longer off than your actual time calculation—you’re on to something. New research shows our different ways of estimating time don’t necessarily move in lock-step. Relative time estimates refer to how distant or close a future event feels, such as “soon” or “far […]
Continue reading »
New research shows that stroke patients are increasingly being transferred out of smaller community and rural hospitals and sent to larger medical centers for their care and rehabilitation. While this is a positive sign for patients who need more advanced treatments, the trend has drawbacks in terms of cost and points to the need to improve the coordination of care […]
Continue reading »
(HealthDay)—One- and two-hour plasma glucose concentrations (1h-PG and 2h-PG, respectively) are similarly effective at predicting diabetic retinopathy (DR), according to a study published online April 5 in Diabetes Care. Ethan Paddock, from the National Institutes of Health in Phoenix, and colleagues assessed the ability of 1h-PG and 2h-PG, derived from a 75-g oral glucose tolerance test (OGTT), to predict DR […]
Continue reading »
Many clinicians advise patients with atrial or ventricular arrhythmias to avoid caffeinated beverages, but recent research has shown that coffee and tea are safe and can reduce the frequency of arrhythmias, according to a review published today in JACC: Clinical Electrophysiology. Arrhythmias, or abnormal heart rhythms, cause the heart to beat too fast, slow or unevenly. While some arrhythmias may […]
Continue reading »
A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was removed, which resulted in fewer relapse cases in the patients. The research teams at the Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy, the Johns Hopkins Sidney Kimmel […]
Continue reading »
For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It’s the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers. In the study, Merck’s Keytruda, given with standard chemotherapy, cut in half the […]
Continue reading »
Education gives people an edge in their later years, helping them to keep dementia at bay and their memories intact, a new USC-led study has found. “This association between the increase in college attainment and the decline in dementia prevalence is good news for people who have completed some higher education or earned a degree, but what does it mean […]
Continue reading »
BLU-667, a next-generation inhibitor that selectively targets the oncogenic receptor tyrosine kinase RET, was well tolerated and had broad clinical benefit in patients with advanced cancer that had progressed on previous therapies including multikinase inhibitor therapy. Proof-of-concept data will be presented from an ongoing phase I clinical trial at the AACR Annual Meeting 2018, April 14-18, in Chicago. “RET-altered cancers […]
Continue reading »
Taking painkillers during pregnancy could affect the fertility of the unborn child in later life, research suggests. The study identifies that these drugs may also affect the fertility of future generations, by leaving marks on DNA. The findings add to a growing body of evidence that certain medicines, including paracetamol, should be used with caution during pregnancy. Researchers stress that […]
Continue reading »
Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center offers a potential explanation for why the disease becomes chemoresistant, and a possible avenue to explore new […]
Continue reading »